Sika AG

LSE:0Z4C Stock Report

Market Cap: CHF 27.0b

Sika Valuation

Is 0Z4C undervalued compared to its fair value, analyst forecasts and its price relative to the market?

Valuation Score

3/6

Valuation Score 3/6

  • Below Fair Value

  • Significantly Below Fair Value

  • Price-To-Earnings vs Peers

  • Price-To-Earnings vs Industry

  • Price-To-Earnings vs Fair Ratio

  • Analyst Forecast

Share Price vs Fair Value

What is the Fair Price of 0Z4C when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.

CHF 262.99
Fair Value
35.7% undervalued intrinsic discount
19
Number of Analysts

Below Fair Value: 0Z4C (CHF169.11) is trading below our estimate of fair value (CHF262.99)

Significantly Below Fair Value: 0Z4C is trading below fair value by more than 20%.


Key Valuation Metric

Which metric is best to use when looking at relative valuation for 0Z4C?

Key metric: As 0Z4C is profitable we use its Price-To-Earnings Ratio for relative valuation analysis.

The above table shows the Price to Earnings ratio for 0Z4C. This is calculated by dividing 0Z4C's market cap by their current earnings.
What is 0Z4C's PE Ratio?
PE Ratio22.6x
EarningsCHF 1.19b
Market CapCHF 27.03b

Price to Earnings Ratio vs Peers

How does 0Z4C's PE Ratio compare to its peers?

The above table shows the PE ratio for 0Z4C vs its peers. Here we also display the market cap and forecasted growth for additional consideration.
CompanyForward PEEstimated GrowthMarket Cap
Peer Average22.8x
CRDA Croda International
29.4x16.51%UK£4.1b
JMAT Johnson Matthey
9.7x-17.38%UK£3.6b
VCT Victrex
19.4x20.79%UK£576.7m
ANTO Antofagasta
32.7x13.21%UK£26.7b
0Z4C Sika
22.6x8.86%CHF 27.0b

Price-To-Earnings vs Peers: 0Z4C is good value based on its Price-To-Earnings Ratio (22.6x) compared to the peer average (22.8x).


Price to Earnings Ratio vs Industry

How does 0Z4C's PE Ratio compare vs other companies in the European Chemicals Industry?

1 CompanyPrice / EarningsEstimated GrowthMarket Cap
0Z4C 22.6xIndustry Avg. 17.4xNo. of Companies11PE01224364860+
1 CompanyEstimated GrowthMarket Cap
No more companies

Price-To-Earnings vs Industry: 0Z4C is expensive based on its Price-To-Earnings Ratio (22.6x) compared to the European Chemicals industry average (17.4x).


Price to Earnings Ratio vs Fair Ratio

What is 0Z4C's PE Ratio compared to its Fair PE Ratio? This is the expected PE Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.

0Z4C PE Ratio vs Fair Ratio.
Fair Ratio
Current PE Ratio22.6x
Fair PE Ratio22.3x

Price-To-Earnings vs Fair Ratio: 0Z4C is expensive based on its Price-To-Earnings Ratio (22.6x) compared to the estimated Fair Price-To-Earnings Ratio (22.3x).


Analyst Price Targets

What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?

The above table shows the analyst 0Z4C forecast and predictions for the stock price in 12 month’s time.
DateShare PriceAverage 1Y Price TargetDispersionHighLow1Y Actual priceAnalysts
CurrentCHF 169.11
CHF 222.11
+31.33%
15.64%CHF 300.00CHF 165.00n/a19
Oct ’26CHF 177.65
CHF 247.28
+39.19%
16.89%CHF 350.00CHF 185.00n/a18
Sep ’26CHF 184.75
CHF 253.00
+36.94%
16.57%CHF 350.00CHF 185.00n/a19
Aug ’26CHF 195.08
CHF 254.58
+30.50%
16.70%CHF 350.00CHF 185.00n/a19
Jul ’26CHF 212.61
CHF 261.48
+22.99%
15.99%CHF 350.00CHF 195.00n/a21
Jun ’26CHF 219.69
CHF 263.81
+20.08%
16.75%CHF 350.00CHF 195.00n/a21
May ’26CHF 205.42
CHF 262.05
+27.57%
17.59%CHF 350.00CHF 195.00n/a19
Apr ’26CHF 213.02
CHF 272.89
+28.11%
15.59%CHF 350.00CHF 210.00n/a19
Mar ’26CHF 227.61
CHF 273.45
+20.14%
15.24%CHF 350.00CHF 209.00n/a20
Feb ’26CHF 234.36
CHF 274.88
+17.29%
15.54%CHF 350.00CHF 200.00n/a21
Jan ’26CHF 215.80
CHF 281.40
+30.40%
14.48%CHF 350.00CHF 209.00n/a21
Dec ’25CHF 228.30
CHF 288.81
+26.50%
11.91%CHF 350.00CHF 220.00n/a21
Nov ’25CHF 242.69
CHF 291.76
+20.22%
13.01%CHF 370.00CHF 220.00n/a21
Oct ’25CHF 280.84
CHF 298.48
+6.28%
12.41%CHF 370.00CHF 230.00CHF 177.6521
Sep ’25CHF 272.00
CHF 296.00
+8.82%
12.83%CHF 380.00CHF 230.00CHF 184.7522
Aug ’25CHF 266.80
CHF 295.00
+10.57%
13.02%CHF 380.00CHF 230.00CHF 195.0822
Jul ’25CHF 255.38
CHF 295.68
+15.78%
12.84%CHF 380.00CHF 230.00CHF 212.6122
Jun ’25CHF 275.08
CHF 294.48
+7.05%
13.05%CHF 380.00CHF 230.00CHF 219.6921
May ’25CHF 263.30
CHF 293.76
+11.57%
13.19%CHF 380.00CHF 230.00CHF 205.4221
Apr ’25CHF 268.64
CHF 290.85
+8.27%
14.61%CHF 390.00CHF 224.00CHF 213.0220
Mar ’25CHF 257.53
CHF 288.19
+11.91%
14.46%CHF 390.00CHF 224.00CHF 227.6121
Feb ’25CHF 239.96
CHF 285.10
+18.81%
15.23%CHF 390.00CHF 230.00CHF 234.3621
Jan ’25CHF 273.60
CHF 283.19
+3.50%
16.06%CHF 380.00CHF 225.00CHF 215.8021
Dec ’24CHF 236.15
CHF 281.10
+19.03%
16.62%CHF 380.00CHF 223.00CHF 228.3021
Nov ’24CHF 215.20
CHF 282.43
+31.24%
16.17%CHF 380.00CHF 223.00CHF 242.6921
Oct ’24CHF 234.10
CHF 298.50
+27.51%
12.95%CHF 380.00CHF 230.00CHF 280.8421
CHF 222.91
Fair Value
24.1% undervalued intrinsic discount
19
Number of Analysts

Analyst Forecast: Target price is more than 20% higher than the current share price, but analysts are not within a statistically confident range of agreement.


Discover undervalued companies

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2025/10/28 03:13
End of Day Share Price 2025/10/27 00:00
Earnings2025/09/30
Annual Earnings2024/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

Sika AG is covered by 35 analysts. 17 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Volker BosseBaader Helvea Equity Research
Zana MamelliBaader Helvea Equity Research
Pierre Sylvain RousseauBarclays